CVI Try AAC online
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
CVI.00083-07v1
14/6/700    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lindsley, M. D.
Right arrow Articles by Morrison, C. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lindsley, M. D.
Right arrow Articles by Morrison, C. J.
Clinical and Vaccine Immunology, June 2007, p. 700-709, Vol. 14, No. 6
1071-412X/07/$08.00+0     doi:10.1128/CVI.00083-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Production and Evaluation of Reagents for Detection of Histoplasma capsulatum Antigenuria by Enzyme Immunoassay{triangledown}

Mark D. Lindsley,1* Heather L. Holland,1,{dagger} Sandra L. Bragg,1 Steven F. Hurst,1 Kathleen A. Wannemuehler,2 and Christine J. Morrison1,{ddagger}

Mycotic Diseases Branch,1 Office of the Director, Division of Food-borne, Bacterial, and Mycotic Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia2

Received 12 February 2007/ Returned for modification 19 March 2007/ Accepted 29 March 2007

The detection of urinary Histoplasma capsulatum polysaccharide antigen (HPA) by enzyme immunoassay (EIA) has proven useful for the presumptive diagnosis of histoplasmosis in AIDS patients. Assay limitations include (i) detection of a largely uncharacterized antigen and (ii) difficulty in reproducibly generating antibodies for use in the EIA. To improve antibody production for use in this test and to better understand the antigen being detected, we compared rabbit antibodies elicited using various immunization schedules, routes, and H. capsulatum-derived antigens. Antibodies were evaluated by EIA for their ability to detect purified H. capsulatum C antigen (C-Ag) and antigenuria. Reported as enzyme immunoassay (EI) units (the A450 with antigen divided by the A450 without antigen), results demonstrated that intravenous immunization of rabbits with whole, killed yeast-phase cells (yeast-i.v. regimen) produced antibodies giving the highest EI values in the C-Ag EIA (mean EI units ± standard deviation, 14.9 ± 0.6 versus 6.4 ± 0.4 for rabbits immunized with C-Ag versus 2.4 ± 0.3 for all other regimens combined). Yeast-i.v. antibodies were highly sensitive for the detection of antigenuria in patients with histoplasmosis, as shown by the following results: 12/12 patients compared to 10/12, 6/12, 3/12, and 3/12, respectively, for antibodies from rabbits immunized with (i) C-Ag; (ii) whole, killed yeast-phase cells administered subcutaneously and intramuscularly; (iii) yeast-phase culture filtrates; and (iv) HPA-positive urine. Rabbits immunized using the yeast-i.v. regimen also gave higher peak antibody titers than rabbits immunized by any other regimen (P < 0.03), and their antibodies were most comparable in reactivity to antibodies produced for use in the standard HPA-EIA test (P < 0.001). Therefore, rabbits immunized using the yeast-i.v. regimen produced the most sensitive antibodies with the highest titers for detection of C-Ag and antigenuria in histoplasmosis patients.


* Corresponding author. Mailing address: 1600 Clifton Road, NE, Mailstop G-11, Atlanta, GA 30333. Phone: (404) 639-4340. Fax: (404) 639-3546. E-mail: mlindsley{at}cdc.gov

{triangledown} Published ahead of print on 11 April 2007.

{dagger} Present address: Strategic Science and Program Unit, Coordinating Center for Infectious Diseases, Mailstop A-02, Centers for Disease Control and Prevention, 1600 Clifton Road, NE, Atlanta, GA 30333.

{ddagger} Present address: Office of Public Health Research, Office of the Director, Mailstop D-72, Centers for Disease Control and Prevention, 1600 Clifton Road, NE, Atlanta, GA 30333.


Clinical and Vaccine Immunology, June 2007, p. 700-709, Vol. 14, No. 6
1071-412X/07/$08.00+0     doi:10.1128/CVI.00083-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Microbiol. Rev. Infect. Immun.
J. Clin. Microbiol. J. Virol. ALL ASM JOURNALS

Copyright © 2007 by the American Society for Microbiology. All rights reserved.